Skanda Life Sciences
Bangalore, India· Est.
Integrated Indian CDMO delivering early‑stage discovery and pre‑clinical services for oncology and infectious disease.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Integrated Indian CDMO delivering early‑stage discovery and pre‑clinical services for oncology and infectious disease.
OncologyInfectious Disease
Technology Platform
An integrated discovery platform combining natural product extraction, high‑throughput screening, medicinal chemistry, structural biology, and DMPK/toxicology to accelerate lead generation and IND‑enabling studies.
Opportunities
Growing demand for cost‑effective early‑stage discovery services in oncology and infectious disease, especially from biotech firms seeking integrated end‑to‑end solutions.
Risk Factors
Intense competition from larger global CDMOs, reliance on client pipeline continuity, and the need to maintain regulatory compliance across diverse therapeutic areas.
Competitive Landscape
Competes with CDMOs such as WuXi AppTec, Syngene, and Cambrex; differentiates through a focus on natural product chemistry and a tightly integrated multidisciplinary discovery team.